Trials / Completed
CompletedNCT00610012
Tumor Registry of Advanced Renal Cell Carcinoma
Clinical Registry Describing Treatment Reality and Therapy Modality of Patients With Metastatic or Locally Advanced Renal Cell Carcinoma Requiring Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (actual)
- Sponsor
- iOMEDICO AG · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this registry is to record information of therapy reality of metastatic or locally advanced Renal Cell Carcinoma by office-based medical oncologists in Germany.
Detailed description
The RCC Registry is a prospective, longitudinal, nation wide cohort study that collects data on the treatment reality of patients with mRCC. At inclusion, data in patient characteristics, comorbidities, tumor characteristics, and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. Patients are followed until death or for a maximum of 3 years.
Conditions
Timeline
- Start date
- 2007-12-01
- Primary completion
- 2020-05-15
- Completion
- 2020-05-15
- First posted
- 2008-02-07
- Last updated
- 2020-05-27
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00610012. Inclusion in this directory is not an endorsement.